10 mEq (750 mg)
Klotrix® (potassium chloride) is a solid, oral dosage form of potassium chloride containing 750 mg of potassium chloride, USP (equivalent to 10 mEq of potassium) in a film-coated wax-matrix tablet. This formulation is intended to provide a controlled release of potassium from the matrix to minimize the likelihood of producing high, localized concentrations of potassium within the gastrointestinal tract. Klotrix is an electrolyte replenisher.
BECAUSE OF REPORTS OF INTESTINAL AND GASTRIC ULCERATION AND BLEEDING WITH CONTROLLED-RELEASE POTASSIUM CHLORIDE PREPARATIONS, THESE DRUGS SHOULD BE RESERVED FOR THOSE PATIENTS WHO CANNOT TOLERATE OR REFUSE TO TAKE LIQUIDS OR EFFERVESCENT POTASSIUM PREPARATIONS OR FOR PATIENTS IN WHOM THERE IS A PROBLEM OF COMPLIANCE WITH THESE PREPARATIONS.
- For the treatment of patients with hypokalemia with or without metabolic alkalosis; in digitalis intoxication; and in patients with hypokalemic familial periodic paralysis. If hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to hypokalemia.
- For prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop, e.g., digitalized patients or patients with significant cardiac arrhythmias.
The use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension is often unnecessary when such patients have a normal dietary pattern and when low doses of the diuretic are used. Serum potassium should be checked periodically, however; and, if hypokalemia occurs, dietary supplementation with potassium-containing foods may be adequate to control milder cases. In more severe cases, and if dose adjustment of the diuretic is ineffective or unwarranted, supplementation with potassium salts may be indicated.
Published Studies Related to Klotrix (Potassium Chloride)
Efficacy of a commercial dentifrice containing 2% strontium chloride and 5%
potassium nitrate for dentin hypersensitivity: a 3-day clinical study in adults
in China. 
silica base without any active ingredient (control dentifrice)... CONCLUSION: In these patients with DH in China, the dentifrice containing 2%
Improving outcome of treatment of kala-azar by supplementation of amphotericin B with physiologic saline and potassium chloride. [2010.11]
Complications of amphotericin B limit its wide application in the treatment of patients with kala-azar. This study was undertaken with an aim to minimize anti-renal complications and severe rigor in course of treatment with this drug... Supplementation of amphotericin B with 500 mL of physiologic saline and 30 mL (60 meq/L) of KCl during treatment could help prevent an increase in serum creatinine levels and severe rigor and would make the treatment of kala-azar with amphotericin B easier.
Comparable clinical outcomes between glucosamine sulfate-potassium chloride and glucosamine sulfate sodium chloride in patients with mild and moderate knee osteoarthritis: a randomized, double-blind study. [2010.07]
CONCLUSION: In this short-term randomized comparison, glucosamine sulfate with potassium salt (GS-K) is as effective in pain relief and as safe as glucosamine sulfate with sodium salt (GS-Na) for treatment of mild and moderate degree knee osteoarthritis.
Effects of potassium chloride and potassium bicarbonate on endothelial function, cardiovascular risk factors, and bone turnover in mild hypertensives. [2010.03]
To determine the effects of potassium supplementation on endothelial function, cardiovascular risk factors, and bone turnover and to compare potassium chloride with potassium bicarbonate, we carried out a 12-week randomized, double-blind, placebo-controlled crossover trial in 42 individuals with untreated mildly raised blood pressure...
Racial differences in potassium homeostasis in response to differences in dietary sodium in girls. [2010.03]
BACKGROUND: Racial differences in the renal disposition of potassium may be related to mechanisms for the greater susceptibility to hypertension in blacks than in whites. OBJECTIVE: Our objective was to study the racial differences in the renin-angiotensin-aldosterone system and in potassium balance in black and white girls consuming a controlled diet that was low in potassium with 2 amounts of sodium intake (low compared with high)... CONCLUSION: The well-known racial difference in urinary potassium excretion appears to be at least in part due to greater renal retention of potassium in black girls.
Clinical Trials Related to Klotrix (Potassium Chloride)
Bioavailability of Potassium From Potatoes and Potassium Gluconate [Recruiting]
Potassium in Haemodialysis Fluids and Haemodynamics [Completed]
In a study published in 1995 in the American Journal of Kidney Diseases, Dolson et al
demonstrated that a rapid decrease of serum potassium concentrations during haemodialysis
would produce a significant increase in systolic blood pressure at the end of the session,
even though there were no clear effects on intra-dialytic blood pressure. The authors
defined this post-dialysis blood pressure behaviour as "rebound hypertension".
Paradoxically, in animal models, other than in the context of end-stage renal disease,
potassium is a vasodilator. Considering that the removal of potassium during the
haemodialysis session could be theoretically modulated in profiles (as with sodium and
bicarbonate), it was deemed suitable to delve deeper into this argument by studying, in
detail, the (non invasive) hemodynamic repercussions of changes in the potassium
concentration of the dialysate. Not being able to linearly modify the concentration, we
decided to divide the dialysis session in 3 tertiles, randomising the patients to all
possible dialysate sequences containing the usual concentration of potassium or two cut-off
points at +1 and - 1 mmol/l. Haemodynamic measurements were performed using a finger
Safety of Continuous Potassium Chloride Infusion in Critical Care [Completed]
Patients in critical care often require supplemental potassium chloride if levels in their
blood are below acceptable level. Common practice is to administer a single dose of
potassium chloride under controlled conditions via a drip, before checking if a further dose
is required. The purpose of this study is to ensure that it is safe to administer potassium
chloride continuously with the dose varied according to patient needs.
Comparison of Two Potassium Targets Within the Normal Range in Intensive Care Patients [Completed]
Rationale: It is well known that distinctly abnormal blood potassium values can cause
serious complications such as cardiac arrhythmias. Although potassium regulation is
generally considered important, hardly any research has been done about potassium regulation
in intensive care patients. The investigators hypothesize that different potassium
target-values, within the as normal accepted range, may have different effects in critically
Study design: A prospective trial comparing two different potassium target-values. Potassium
will be tightly regulated with the already fully operational GRIP-II computer program.
Study population: 1200 adult patients admitted at the thoracic intensive care unit of the
University Medical Center Groningen.
Intervention: Comparison between two variations of standard therapy: potassium target-value
of 4. 0 mmol/L versus 4. 5 mmol/L.
Main study parameters/endpoints: The primary endpoint is the incidence of atrial
fibrillation or atrial flutter from ICU-admission to hospital discharge. Secondary endpoints
are serum levels of potassium and the other main electrolytes, renal function and renal
potassium excretion, the relation with insulin and glucose, the cumulative fluid balance,
(ICU) length of stay and mortality.
The Effects of Sodium and Potassium on Blood Pressure, Vascular Function and Renal Function [Completed]
Page last updated: 2013-02-10